PPARG and acute kidney injury: In this study, a CI-AKI model was established using Sprague Dawley (SD) rats, which were intervened with rosiglitazone and PPARγ inhibitor, to explore whether rosiglitazone can alleviate CI-AKI, its renoprotective functions, and the underlying signaling pathway through which rosiglitazone played its role.